HMZ 2.0 Intervention for Pregnancy Weight Management
(HMZ Two Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new digital platform designed to help pregnant women manage weight gain and improve sleep and eating habits. Researchers aim to determine if this approach can positively impact both maternal health and baby outcomes. Participants will either use this new system, called the HMZ 2.0 Intervention, or receive guidance on managing pain without medication during and after childbirth. The trial seeks pregnant women who are 8 to 18 weeks along, expecting a single baby, and are overweight or obese. Participants must weigh themselves daily, wear an activity tracker, complete online surveys, and attend weekly sessions with a dietitian. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could benefit future mothers and babies.
Do I need to stop my current medications to join the trial?
The trial does not specify if you need to stop taking your current medications, but you cannot be using weight loss medications to participate.
What prior data suggests that the HMZ 2.0 intervention is safe for pregnant women?
Research shows that the HMZ 2.0 program helps pregnant women manage their weight healthily. Past studies indicate that similar programs are usually well-received by participants, with no major reports of unwanted side effects.
This trial emphasizes behavior and lifestyle changes rather than testing a new drug or medical device, which generally poses lower safety risks compared to drug trials. Participants set goals, track their progress, and learn about health topics. These activities are generally safe and aim to support healthy habits during pregnancy.12345Why are researchers excited about this trial?
Researchers are excited about the HMZ 2.0 Intervention for pregnancy weight management because it offers a personalized and comprehensive approach to health during pregnancy. Unlike traditional methods that may focus solely on diet or exercise, this intervention combines weekly one-on-one sessions with a registered dietitian and integrates education on gestational weight gain, physical activity, nutrition, and stress management. Additionally, it leverages mHealth tools for self-monitoring and provides evidence-based insights on how a mother's health impacts fetal growth, making it a holistic and engaging option for expectant mothers.
What evidence suggests that this trial's treatments could be effective for managing gestational weight gain?
Research has shown that the HMZ 2.0 program, which participants in this trial may receive, helps pregnant women manage weight gain effectively. Women who have used this program achieved positive results by following personalized plans and using digital tools to track progress. The program also improves exercise, eating habits, and sleep, which are crucial for managing weight and maintaining health during pregnancy. The digital platform offers personalized advice and feedback, making it easier for expectant mothers to adhere to their health goals. Early results suggest that this comprehensive approach can lead to better health for both mother and baby. Meanwhile, participants in the attention control group will receive education on preparing for labor and behavioral pain management strategies, designed to support healthy prenatal behaviors.12367
Are You a Good Fit for This Trial?
This trial is for pregnant women aged 18-45, with a BMI of 25.0 to 45.0, living in specific areas of Pennsylvania. They must be at 8-15 weeks gestation and have their doctor's consent to participate. Women over a BMI of 40 will need extra checks from their healthcare provider.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-intervention
Participants complete assessments and a 10-day free-living period to establish baseline data
Treatment
Participants engage in weekly sessions with a registered dietitian and daily self-monitoring using mHealth tools
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Attention Control Intervention
- HMZ 2.0 Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Penn State University
Lead Sponsor
Arizona State University
Collaborator